氟比洛芬酯注射液致精神异常1例分析

doi:10.19803/j.1672-8629.2020.10.16

中国药物警戒 ›› 2020, Vol. 17 ›› Issue (10): 724-725.
DOI: 10.19803/j.1672-8629.2020.10.16

氟比洛芬酯注射液致精神异常1例分析

易勤, 谭秋红, 罗圣平^*

株洲市中心医院,湖南株洲412000

收稿日期:2020-10-14 修回日期:2020-10-14 出版日期:2020-10-15 发布日期:2020-10-13
通讯作者: ^*罗圣平,男,本科,主任药师,临床药学。E-mail：1483231497@qq.com
作者简介:易勤,女,硕士,药师,临床药学。

Analysis of Mental Abnormality Induced by Flurbiprofen Axetil Injection

YI Qin, TAN Qiuhong, LUO Shengping^*

Department of Pharmacy, Zhuzhou Central Hospital, Zhuzhou Hunan 412000, China

Received:2020-10-14 Revised:2020-10-14 Online:2020-10-15 Published:2020-10-13

摘要/Abstract

摘要： 目的提醒医务人员在使用氟比洛芬酯注射液时应密切关注用药安全。方法分析1例车祸后右小腿疼痛伴活动受限的患者,因术后使用氟比洛芬酯注射液镇痛而导致的精神异常的病例资料。结果该患者出现神志不清,胡言乱语,躁动等精神异常表现可能由氟比洛芬酯注射液引起的,及时停药后,患者家属诉未出现之前的症状,患者无神经系统后遗症。结论氟比洛芬酯注射液导致的精神异常发生率低,及时停药预后良好,但容易掩盖病情,应引起临床重视。

关键词: 氟比洛芬酯注射液, 不良反应, 精神异常

Abstract: Objective To remind the medical staff to pay close attention to medication safety of flurbiprofen axetil injection. Methods A case of right leg pain with limited movement after traffic accident was retrospectively analyzed, which became mental abnormality caused by postoperative analgesia with flurbiprofen axetil injection. Results Flurbiprofen axetil injection may be the cause of mental abnormality such as delirium, gibberish, agitation, etc. After timely withdrawal of the drug, the family members of the patient complained that there were no previous symptoms, and the patient had no neurological sequelae. Conclusion Flurbiprofen axetil injection caused by low incidence of mental abnormality, timely withdrawal of the drug has a good prognosis, but it is easy to cover up the disease, which deserves attention.

Key words: flurbiprofen axetil injection, adverse reactions, mental abnormality

中图分类号:

R994.11

易勤, 谭秋红, 罗圣平. 氟比洛芬酯注射液致精神异常1例分析[J]. 中国药物警戒, 2020, 17(10): 724-725.

YI Qin, TAN Qiuhong, LUO Shengping. Analysis of Mental Abnormality Induced by Flurbiprofen Axetil Injection[J]. Chinese Journal of Pharmacovigilance, 2020, 17(10): 724-725.

参考文献

[1] Kertmen N, Babacan T, Keskin O, et al.Molecular subtypes in patients with inflammatory breast cancer; a single center experience[J]. J BUON, 2015, 20(1): 35-39.
[2] Zhao X, Flurbiprofen axetil: Analgesic effect and adverse reaction[J]. Pakistan Journal of Pharmaceutical Sciences, 2018, 31(3 Special): 1163-1167.
[3] Wu TW.Analysis of 1 case of convulsion caused by flurbiprofen axetil[J]. Chinese Journal of Misdiagnosis(中国误诊学杂志), 2007, 7(19): 4679.
[4] Huang XF, Yu AR, Li Q.A case of flurbiprofen axetil-induced disturbance of consciousness and convulsions[J]. Chinese Journal of Pharmacoepidemiology(药物流行病学杂志), 2011, 20(10): 562.
[5] Sun W.Flurbiprofen axetil, nasal polyps, and status asthmaticus: an unusual case report[J]. The Journal of Asthma, 2011, 48(6): 647-649.
[6] Qi F, Zhang T, Wu LL.One case of adverse reaction caused by compound osteopeptide injection and flurbiprofen axetil injection[J]. China Pharmacist(中国药师), 2014, 17(7): 1202-1203.
[7] Zhang L, Zhu J, Xu L, et al.Efficacy and safety of flurbiprofen axetil in the prevention of pain on propofol injection: a systematic review and meta-analysis[J]. Medical science monitor, 2014, 20: 995-1002.
[8] Giovannini M, Sarti L, Barni S, et al.Anaphylaxis to Over-the-Counter Flurbiprofen in a Child[J]. Pharmacology, 2017, 99(3-4): 121-123.
[9] Zhou M, Li B.Effects of Flurbiprofen Axetil on Postoperative Analgesia and Cytokines in Peripheral Blood of Thoracotomy Patients[J]. Cell biochemistry and biophysics, 2015,72(2): 429-432.
[10] Wang K, Luo J, Zheng L.Preoperative flurbiprofen axetil administration for acute postoperative pain: a meta-analysis of randomized controlled trials[J]. Journal of Aanesthesia, 2017, 31(6): 852-860.
[11] Peng L, Xu L.Role of peripheral inflammatory markers in postoperative cognitive dysfunction (POCD): a meta-analysis[J].PloS one, 2013, 8(11): e79624.
[12] Wu MD, Montgomery SL, Rivera-Escalera F, et al.Sustained IL- 1β expression impairs adult hippocampal neurogenesis independent of IL-1 signaling in nestin+ neural precursor cells[J].Brain, Behavior, and Immunity, 2013, 32: 9-18.
[13] Zhou ZJ, Tang J, Li WH.Preoperative intravenous flurbiprofen reduces postoperative pain and inflammatory cytokines in elderly patients after hip arthroplasty[J]. Experimental and Therapeutic Medicine, 2019, 17(1): 354-358.
[14] Terrando N, Rei Fidalgo A, Vizcaychipi M, et al.The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction[J].Critical Care, 2010, 14(3): R88.
[15] He HJ, Wang Y, Le Y, et al.Surgery Upregulates High Mobility Group Box-1 and Disrupts the Blood-Brain Barrier causing Cognitive Dysfunction in Aged Rats[J].CNS Neuroscience & Therapeutics, 2012, 18(12): 994-1002.

氟比洛芬酯注射液致精神异常1例分析

Analysis of Mental Abnormality Induced by Flurbiprofen Axetil Injection

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	贾晋生, 刘红亮, 王青, 侯永芳, 李馨龄. 基于知识图谱联合ERNIE-DPCNN模型的药品不良反应自动关联性评价方法研究[J]. 中国药物警戒, 2024, 21(2): 163-166.
[2]	李应芬, 韩雷. 319例注射用脑蛋白水解物药品不良反应报告分析[J]. 中国药物警戒, 2024, 21(2): 195-198.
[3]	徐伟佳, 彭崎, 黄海渝, 张磊姣, 肖华, 吴雪. 285例新型抗肿瘤药物不良反应分析[J]. 中国药物警戒, 2024, 21(2): 199-203.
[4]	郭清华, 彭笑笑, 朱萍, 刘西霖, 杨颖华, 陈志海. 氨氯地平过量致多器官功能障碍综合征1例分析[J]. 中国药物警戒, 2024, 21(2): 204-207.
[5]	方美琳, 郑慧敏, 王存泽, 王凌, 阮君山. 注射用奥沙利铂致全身肌肉疼痛1例分析[J]. 中国药物警戒, 2024, 21(2): 208-210.
[6]	陈玉艳, 张明霞, 张涛, 张晋. 斯鲁利单抗注射液致间质性肺炎不良反应1例分析[J]. 中国药物警戒, 2024, 21(2): 213-215.
[7]	曹桂萍, 邓琳琳, 朱干红, 陆颖, 马爽, 陈玲玲, 刘丽丽. 天麻首乌片致严重肝损伤1例分析[J]. 中国药物警戒, 2024, 21(2): 216-218.
[8]	朱盈, 沈璐, 李岚, 吴建民, 高晓洁. 新法规体系下我国牙膏不良反应监测工作分析与思考[J]. 中国药物警戒, 2024, 21(2): 219-222.
[9]	高云娟, 赵旭, 白天凯, 柏兆方, 王伽伯, 宋海波, 肖小河. 基于不良反应监测大数据的药品安全风险发现与识别策略[J]. 中国药物警戒, 2024, 21(1): 1-5.
[10]	郭龙鑫, 高云娟, 吴承钊, 龙敏娟, 祝胜凯, 宋海波, 赵旭, 肖小河. 基于不良反应监测大数据的中药药源性肝损伤风险信号新发现及易感因素初探[J]. 中国药物警戒, 2024, 21(1): 15-19.
[11]	蒋文硕, 杨莉. 694例癫痫医师药师联合门诊患者药品不良反应分析[J]. 中国药物警戒, 2024, 21(1): 102-106.
[12]	陈华炎, 江东波, 郭春连, 杨家琪, 黎雨欣, 蔡伟明. 326例奈玛特韦片/利托那韦片治疗新型冠状病毒感染安全性分析[J]. 中国药物警戒, 2024, 21(1): 107-110.
[13]	刘赛月, 吕小琴, 周耘. 疑似药品不良反应死亡病例调查及报告实施要点[J]. 中国药物警戒, 2023, 20(9): 971-974.
[14]	里筱竹, 王蔷, 逄瑜, 张轶菁. 个例药品不良反应报告管理浅析与思考[J]. 中国药物警戒, 2023, 20(9): 975-977.
[15]	逄瑜, 刘博, 吕少俐, 王涛, 邢颖, 秦星宇, 田月洁, 吴文宇. 基于国际药物警戒经验探讨收集患者报告的意义[J]. 中国药物警戒, 2023, 20(9): 978-981.